Silvia Bertagnolio - Concepedia

Author

Silvia Bertagnolio

Also Known As

Avelin Fobang Aghokeng, Bertagnolio, Silvia, Maria Daniela Bergamasco, S Bertagnolio, S. Bertagnolio, Silvia Bertagnolio

149

Publications

7.8K

Citations

H-Index

Concepts

All Affiliations

World Health Organization Tufts University University College London World Health Organization - Pakistan Centers for Disease Control and Prevention

About

Silvia Bertagnolio is an author at World Health Organization specializing in hiv, medicine, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	26	1.6K
2	Public Health	17	17	1.2K
3	Health Sciences	5	5	130
4	Social Sciences	1	1	40
5	Biostatistics	1	1	25

Silvia Bertagnolio

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis Ravindra K. Gupta, Michael R. Jordan, Binta Sultan, The Lancet Sexual HealthPreventive MedicineTreatment And PreventionMedicineGlobal Health	2012	360
Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment Diane Bennett, Mark Myatt, Silvia Bertagnolio, Antiviral Therapy	2008	286
The World Health Organization's global strategy for prevention and assessment of HIV drug resistance Diane Bennett, Silvia Bertagnolio, Donald Sutherland, Antiviral Therapy World Health OrganizationPharmacotherapyAntiviral DrugDrug ResistancePreventive Medicine	2008	269
World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites Michael R. Jordan, Diane Bennett, Silvia Bertagnolio, Antiviral Therapy	2008	193
Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform of COVID-19 Silvia Bertagnolio, Soe Soe Thwin, Ronaldo Silva, The Lancet HIV	2022	188
Pharmacy Adherence Measures to Assess Adherence to Antiretroviral Therapy: Review of the Literature and Implications for Treatment Monitoring James McMahon, Michael R. Jordan, Kent R. Kelley, Clinical Infectious Diseases	2011	144
Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study Andrew Phillips, François Venter, Diane V. Havlir, The Lancet HIV	2018	122
Impact of HIV Drug Resistance on HIV/AIDS-Associated Mortality, New Infections, and Antiretroviral Therapy Program Costs in Sub–Saharan Africa Andrew Phillips, John Stover, Valentina Cambiano, The Journal of Infectious Diseases	2017	121
HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing Soo‐Yon Rhee, Michael R. Jordan, Elliot Raizes, PLoS ONE Treatment And PreventionHuman RetrovirusAnalyzed Virus SequencesAntiviral TherapyResistance Mutation (Virology)	2015	92
Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance Philip L. Tzou, Soo‐Yon Rhee, Diane Descamps, Journal of Antimicrobial Chemotherapy	2019	81

Page 1